Navigation Links
Study points to potential new use for Viagra
Date:8/26/2008

(Kingston, ON) A "basic science" breakthrough by Queen's University researchers into regulating a single enzyme may lead to new drug therapies that will help prevent heart attacks and strokes.

Led by professor of Pharmacology and Toxicology Donald Maurice, the study focuses on the effects of Viagra the popular erectile dysfunction drug, which is also used to treat pulmonary hypertension.

The team's findings will be published on-line this week in the international journal Proceedings of the National Academy of Sciences (PNAS).

"As scientists, we're excited about this discovery because it's a fundamentally new approach to regulating what enzymes do in cells," says Dr. Maurice, a Career Scientist with the Ontario Heart and Stroke Foundation. "The fact that it also offers a potentially novel use of a drug already widely in use for other applications is an unexpected bonus."

The enzyme targeted by the Queen's researchers is known to regulate the activity of platelets: small blood cells needed for normal blood clotting. Problems can arise when people have stents permanently implanted in their arteries to maintain blood flow. Their platelets sometimes bind to the stent and, if enough platelets accumulate to form a blockage, this may cause a sudden, massive heart attack or stroke to occur.

Drugs like Viagra have been shown to inhibit PDE5, explains Lindsay Wilson, a PhD student in Pathology and Molecular Medicine and first author on the study. Until now, however, it hasn't been possible to isolate the small "pool" of activity within the cell where this is occurring.

The Queen's study shows that within each cell there are two different pools of the PDE5 enzyme, but that only one of them regulates platelet activation. "Understanding how the cell works should allow us to affect the activity of enzymes in one neighborhood and leave alone their 'identical twins' in a different neighborhood in that cell," says Ms Wilson.

"The idea is to use a PDE5 inhibitor such as Viagra selectively to inhibit platelet function," she continues. We now know that not all the enzymes in the cell are doing the same job. Just like in real estate, it's all about the location!"


'/>"/>

Contact: Nancy Dorrance
nancy.dorrance@queensu.ca
613-533-2869
Queen's University
Source:Eurekalert  

Related biology news :

1. Unique study shows oil, gas seismic work not affecting Gulf sperm whales
2. ETH Zurich study on salmonella self-destruction
3. Researchers study facial structures, brain abnormalities to reveal formula for detection of autism
4. Childrens national co-leads nationwide study of landmark sickle cell treatment
5. Largest study of its kind implicates gene abnormalities in bipolar disorder
6. Sweets make young horses harder to train in Montana State study
7. Light receptors in eye play key role in setting biological clock, study shows
8. Researchers to study lyme-like illness in Texas
9. Study shows continued spread of dead zones
10. Studying volcanoes with balloons
11. Study reveals surprising details of the evolution of protein translation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study points to potential new use for Viagra
(Date:12/22/2016)... -- SuperCom (NASDAQ:   SPCB ... Public Safety, HealthCare, and Finance sectors announced today that Leaders in ... implement and deploy a community-based supportive services program to reduce recidivism ... further expanding its presence in the state. ... This new program, which is expected to ...
(Date:12/16/2016)... Research and Markets has announced the addition of the "Biometric ... to their offering. ... The biometric vehicle access system market, in terms of value, ... to 2021. The market is estimated to be USD 442.7 Million ... The growth of the biometric vehicle access system market is fueled ...
(Date:12/15/2016)... , Dec. 15, 2016 ... driving experience, health wellness and wellbeing (HWW), ... one in three new passenger vehicles begin ... recognition, gesture recognition, heart beat monitoring, brain ... monitoring, facial monitoring, and pulse detection. These ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... for Clinical Ops Executives 2017 in its continued commitment to the advancement of ... makers to discuss current issues related to clinical trial planning and management. ...
(Date:1/18/2017)... ... January 18, 2017 , ... Announced in December 2016, ... (MII). U.S. Secretary of Commerce Penny Pritzker has announced the award of a ... Defense has announced the award of a new Advanced Regenerative Manufacturing Institute (ARMI). ...
(Date:1/18/2017)... PRUSSIA, PA (PRWEB) , ... January 18, 2017 ... ... clinical operations again at the CHI SCOPE Summit for Clinical Ops Executives (Hyatt ... in engaging panel discussions to examine vital clinical research issues such as trial ...
(Date:1/18/2017)... , ... January 18, 2017 , ... Thirty-six startup companies ... credits by the Pennsylvania Department of Community and Economic Development in 2016 as part ... located in the University City Keystone Innovation Zone and represent the highest number of ...
Breaking Biology Technology: